Drug-Resistant Infections
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
This report examines the economic and development consequences of antimicrobial resistance(AMR)—the capacity that disease-causing microorganisms acquire to resist the drugs we've createdto fight them. The report uses World Bank Group economic simulation tools to put a price tag onAMR's destructive impacts on the global economy from 2017 through 2050, if adequate measuresaren't taken to contain the AMR threat. The report highlights actions low- and middle-income countries and their development partners can take to counter AMR, and estimates the investment required. It shows that putting resources into AMR containment now is one of the highest-yield investments countries can make. Antimicrobials are drugs that destroy disease-causing microbes, also called pathogens, such as certain bacteria, viruses, parasites, and fungi. The most familiar and important antimicrobials are antibiotics, which treat bacterial infections. Other antimicrobials combat viral and parasitic diseases, such as AIDS and malaria. Since their use began some 70 years ago, antimicrobials have saved hundreds of millions of lives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Food Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
Analysis and valuation of the health and climate change cobenefits of dietary change
Springmann, M., Godfray, H. C. J., Rayner, M., & Scarborough, P. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523119113 · Cited by 1,262
Global health 2035: a world converging within a generation
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62105-4 · Cited by 1,220
van Cleef, B. A. G. L., van Benthem, B. H. B., Verkade, E. J. M., van Rijen, M. M. L., Kluytmans-van den Bergh, M. F. Q., Graveland, H., Bosch, T., Verstappen, K. M. H. W., Wagenaar, J. A., Bos, M. E. H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127190 · Cited by 56
Cited by
Global geographic trends in antimicrobial resistance: the role of international travel
Frost, I., Van Boeckel, T. P., Pires, J., Craig, J., & Laxminarayan, R. (2019) · Journal of Travel Medicine · doi:10.1093/jtm/taz036 · Cited by 338
Ajulo, S., & Awosile, B. (2024) · PLOS ONE · doi:10.1371/journal.pone.0297921 · Cited by 267
Kimera, Z. I., Mshana, S. E., Rweyemamu, M. M., Mboera, L. E. G., & Matee, M. I. N. (2020) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-020-0697-x · Cited by 256
A Systematic Review of Pharmacist-Led Antimicrobial Stewardship Programs in Sub-Saharan Africa
Otieno, P. A., Campbell, S., Maley, S., Obinju Arunga, T., & Otieno Okumu, M. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/3639943 · Cited by 92
Impact of Remote Consultations on Antibiotic Prescribing in Primary Health Care: Systematic Review
Han, S. M., Greenfield, G., Majeed, A., & Hayhoe, B. (2020) · Journal of Medical Internet Research · doi:10.2196/23482 · Cited by 80
Metadata
- Authors
- Bank, W.
- Venue
- World Bank, Washington, DC eBooks
- Publisher
- World Bank, Washington, DC
- Published
- 2017-03
- OpenAlex
- W4248599173
- Cited by
- 152
- References
- 6
- FWCI
- 11.57
- Type
- book
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug-Resistant Infections. https://app.cochat.ai/papers/10.1596/26707
- The paper
- Bank, W. (2017). Drug-Resistant Infections. World Bank, Washington, DC eBooks. https://doi.org/10.1596/26707
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.